Dermatology

RepeatMD Surpasses 1 Million Users and Ranks Top 200 Most Popular Shopping Apps

Retrieved on: 
Thursday, May 9, 2024
Online Retail, Retail, Health, Apps, Applications, Technology, Software, General Health, Laser, AI, Software as a service, EBay, Dermatology, Patient, Apple, Human

While reaching this major milestone, RepeatMD has also made it to the Top 200 most popular apps in the Apple App Store’s elusive “Shopping” category, ranking as high as #126.

Key Points: 
  • While reaching this major milestone, RepeatMD has also made it to the Top 200 most popular apps in the Apple App Store’s elusive “Shopping” category, ranking as high as #126.
  • It has beat out popular shopping apps like Ebay, Olo, and SSENSE.
  • Both achievements represent major milestones for RepeatMD on its mission to help providers conveniently grow their practices while focusing on what matters most: transforming patients’ lives.
  • We’ve invented a new type of ecommerce for the health and wellness space and there’s still much more to come.”

Worldwide Dermatology Deals Collection, 2016-2024: Gain Access to Benchmark Analysis, Financial Terms, Leading Deals, Active Dealmakers, and Contract Documents of 452 Dermatology Deals - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 8, 2024
Health, Pharmaceutical, Hyperlink, Dermatology, Confidentiality, Record, A-Z, Directory, Intellectual property, Lease

Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the world's leading biopharma companies.

Key Points: 
  • Dermatology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the dermatology deals entered into by the world's leading biopharma companies.
  • Fully revised and updated, the report provides details of 452 dermatology deals from 2016 to 2024.
  • Dermatology Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of dermatology trends and structure of deals entered into by leading biopharma companies worldwide.
  • Dermatology Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

LEO Pharma Announces Topline Results of Phase 3 Trial in China for Enstilar® (LEO 90100) Demonstrating Superiority in Adult Chinese Subjects With Stable Plaque Psoriasis

Retrieved on: 
Tuesday, May 7, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Phase, LEO, Hope, Hospital, Safety, Leo Pharma, Patient, Psoriasis, Plaque, Dermatology, Pharmaceutical industry

LEO Pharma A/S, a global leader in medical dermatology, today announces positive results from the Enstilar® phase 3 trial in China in adult patients living with stable plaque psoriasis.

Key Points: 
  • LEO Pharma A/S, a global leader in medical dermatology, today announces positive results from the Enstilar® phase 3 trial in China in adult patients living with stable plaque psoriasis.
  • Exploratory objectives included evaluating health-related quality of life.1
    The topline results show that Enstilar demonstrated superiority to Daivobet ointment in the primary objective.
  • Following the results, LEO Pharma will proceed with preparations to submit Enstilar for approval with the Chinese authorities.
  • Detailed results from the Enstilar China trial will be submitted for scientific presentation and publication at a later date.

ONOXA Unveils Their First Line of Men's Products

Retrieved on: 
Wednesday, May 8, 2024
Safety, Skin, Dermatology, Business development, Collection, ISO, Castor oil, Attention, Printing, MEN, Cosmetics

LARGO, Fla., May 8, 2024 /PRNewswire/ -- ONOXA, a leading name in private label skincare, proudly announces the launch of its latest collection tailored specifically for men. The new line features a range of meticulously crafted products designed to elevate every man's skincare routine to new heights of sophistication and efficacy.

Key Points: 
  • The new line features a range of meticulously crafted products designed to elevate every man's skincare routine to new heights of sophistication and efficacy.
  • Dermatologists: Enhance your brand with seamlessly integrated new products, elevating an existing line.
  • Explore ONOXA's range of premium products, seamless processes, and unparalleled support designed to make one's brand stand out in the competitive market.
  • Whether one is just starting out or looking to expand, ONOXA is here to help every step of the way.

CLn Skin Care Expands Medical Advisory Board

Retrieved on: 
Tuesday, May 7, 2024
Education, Dermatitis, San Diego Magazine, CLN, System, Montefiore Medical Center, Skin, Health, Cosmetics, Pediatrics, Skin care, Folliculitis, DRS, MAB, Patient, Face, Optum, Northern Westchester Hospital, Francis Parker, Dermatology, Pharmacology, Northwell Health, Nursing

DALLAS, May 7, 2024 /PRNewswire/ -- CLn Skin Care, the innovative brand known for its breakthrough line of gentle yet effective cleansers for the face and body, today announces the appointment of two distinguished physician leaders to its esteemed medical advisory board (MAB) of the company: Shakha Gillin, MD, FAAP, and Doug Krohn, MD, FAAP. Adding the new Pediatric Medicine specialists to CLn's medical advisory board further reinforces the brand's commitment to advancing skin health for all ages through diverse expertise and insights.

Key Points: 
  • Adding the new Pediatric Medicine specialists to CLn's medical advisory board further reinforces the brand's commitment to advancing skin health for all ages through diverse expertise and insights.
  • CLn Skin Care appoints two physician leaders to its medical board: Shakha Gillin, MD, FAAP, and Doug Krohn, MD, FAAP.
  • Shakha Gillin, MD, FAAP, brings a wealth of experience in pediatric medicine and preventative care to CLn Skin Care.
  • Dr. Doug Krohn, a distinguished primary care pediatrician and specialist in neonatal care and cognitive behavior therapy, adds a unique perspective to CLn Skin Care's board of directors.

AMERICAN ACADEMY OF DERMATOLOGY SURVEY SHOWS OUTDOOR WORKERS MORE AT RISK FOR SKIN CANCER THAN AVERAGE AMERICANS

Retrieved on: 
Tuesday, May 7, 2024
Moles, UPF, American Academy, University, Cancer, Perspiration, Blister, Carcinoma, Risk, Skin, Burn, American Academy of Dermatology, Hand, MD, Dermatology, Sunburn, Skin cancer, Life, Tanning, AAD, Melanoma, SPF, Human, Swimming, Emergency medical services, UV, Clothing, Cosmetics

ROSEMONT, Ill., May 7, 2024 /PRNewswire/ -- A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers – like those who work in construction, landscaping, emergency medical services, and postal delivery – are far more likely to get sunburned and tanned, putting themselves at increased risk for skin cancer, compared to the average American. In recognition of Skin Cancer Awareness Month this May, the AAD encourages everyone – and especially those who work outdoors – to practice safe sun to protect themselves from the sun's harmful rays and reduce their risk of developing skin cancer.

Key Points: 
  • According to the survey, half of outdoor workers were sunburned in 2023, compared to 36 percent reported by the general American population.
  • One in 10 outdoor workers had sunburns severe enough to cause blisters, a rate double that of the general population.
  • And nearly 80 percent of outdoor workers got a tan or darker skin as a result of sun exposure, compared to 67 percent of Americans overall.
  • Tanning and unprotected sun exposure are major risk factors for skin cancer, the most common form of cancer in the United States and one of the most preventable types of cancer.

DermCare Management Expands with New Partnerships in the Greater Dallas Area

Retrieved on: 
Monday, May 6, 2024
American Medical Association, Dermatology, AAD, Health, Continuing medical education, Knowledge, Veterinary medicine

DermCare Management welcomes Dr. Christine Brown Dermatology and Dr. Kim Dermatology to the DermCare family of Texas dermatology practices.

Key Points: 
  • DermCare Management welcomes Dr. Christine Brown Dermatology and Dr. Kim Dermatology to the DermCare family of Texas dermatology practices.
  • Joining Dermatology Treatment and Research Center in Dallas, TX, and Stone Oak Dermatology in San Antonio, TX,  these two newly acquired practices further cement DermCare Management's commitment to supporting exceptional patient care in the Lone Star state.
  • Both Dr. Christine Brown and Dr. Kim Werner Billet bring a wealth of knowledge and specialized experience to DermCare Management.
  • We invite any private practice dermatologist looking to leverage our business management expertise and solidify their presence in their community to connect with DermCare Management to learn about our personalized support services and partnerships."

Dr. Ahmed Z. Obeidat Named Finalist for the 2024 "CMSC Neuroinnovator of the Year"

Retrieved on: 
Monday, May 6, 2024
Dementia, Prevalence, Dermatology, Cognition, Thought, Research, Light, Background, Patient, Fatigue, Psoriasis, Biomarker, Light therapy, Walking, CMSC, Medical college, Pharmaceutical industry

"This trial targets the biggest unmet need in MS, which is fatigue and the cognitive difficulties associated with it. The trial will be able to detect changes in improved fatigue, stabilization, and maybe even improve cognition," said Dr. Obeidat. "I think the inclusive target patient population within the Silent Symptoms trial will change our thinking about who should be enrolled in clinical trials. Most trials have been very selective -- excluding people who are not walking, or are over age 60, and so on. The Silent Symptoms trial will go all in, taking any MS patient with fatigue, which is the vast majority of our patients, and offering them phototherapy lights that they can take home."

Key Points: 
  • The recognition highlights the groundbreaking work and innovative approach sponsored by Cytokind, Inc. in addressing unmet needs in MS treatment.
  • The trial will be able to detect changes in improved fatigue, stabilization, and maybe even improve cognition," said Dr. Obeidat.
  • The 2024 CMSC Neuroinnovation Competition aims to recognize and celebrate original and innovative work in the field of MS research.
  • The finalists will present their ideas at the annual CMSC conference in Nashville, Tennessee, from May 29 to June 1.

Waccamaw Dermatology Opens New Office In Mount Pleasant

Retrieved on: 
Monday, May 6, 2024
Mohs, Skin, Carcinoma, Health, Dermatology, Skin cancer, Patient, Physician, Elective surgery, Ageing, Cancer, Mohs surgery, Hospital

MOUNT PLEASANT, S.C., May 6, 2024 /PRNewswire-PRWeb/ -- Waccamaw Dermatology, one of the largest physician-owned and led dermatology practices in the Carolinas, today announced the opening of a new office to serve the Mount Pleasant area. The new office — the eleventh in the multi-award-winning Waccamaw Dermatology practice — expands access to skin cancer screening to a population that needs quality dermatological care. Skin cancer screening is recommended beginning in a person's mid-20s, but studies show it still lags behind screening for other types of cancers. Waccamaw Dermatology currently operates

Key Points: 
  • MOUNT PLEASANT, S.C., May 6, 2024 /PRNewswire-PRWeb/ -- Waccamaw Dermatology , one of the largest physician-owned and led dermatology practices in the Carolinas, today announced the opening of a new office to serve the Mount Pleasant area.
  • The new office — the eleventh in the multi-award-winning Waccamaw Dermatology practice — expands access to skin cancer screening to a population that needs quality dermatological care.
  • Waccamaw Dermatology currently operates
    "Waccamaw Dermatology is committed to providing the best clinical care and patient experience for dermatology patients in the Carolinas," said Brandon J. Coakley, M.D., Board-Certified Dermatologist, fellowship-trained Mohs Surgeon, and Managing Partner of Waccamaw Dermatology.
  • The opening of the new Mount Pleasant office is driven by consistent demand for quality dermatology offices.

Survey Shows Stark Difference in Satisfaction Rates Among Skin Cancer Patients Treated Surgically and Nonsurgically

Retrieved on: 
Wednesday, May 1, 2024
Pain, Mohs surgery, Skin, Risk, Private practice, Commonwealth, Dermatology, Skin cancer, SRT, Patient, Medical imaging

The survey involved 3,915 individuals who had been treated for nonmelanoma skin cancer one or more times.

Key Points: 
  • The survey involved 3,915 individuals who had been treated for nonmelanoma skin cancer one or more times.
  • SkinCure Oncology Chief Executive Officer Kerwin Brandt explained, "With GentleCure, we're providing cancer center level of care in the private practice.
  • Dermatologists across the country are celebrating the introduction of this nonsurgical treatment for the nation's most common cancer type – nonmelanoma skin cancer.
  • While May is Skin Cancer Awareness Month, early-adopter skin specialists in 40 states are already providing the GentleCure Experience to patients who prefer to avoid surgery or for whom surgery is not recommended.